- Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease.
- The Hitchhiker's Guide to Nucleocytoplasmic Trafficking in Neurodegeneration.
- Current Advances in Allosteric Modulation of Muscarinic Receptors.
- Pridopidine in the treatment of Huntington's disease.
- Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication.
- Author Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
- A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra.
- Emerging roles for high-density lipoproteins in neurodegenerative disorders.
- Evaluating a genetic counseling narrative group session for people who have tested positive for the Huntington's disease expansion: An interpretative phenomenological analysis.
- Structural basis of ligand recognition and self-activation of orphan GPR52.
- The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.
- Choreo-Athetosis and Ataxia as Leading Features in a Case of Erdheim-Chester Disease.
- Nosology and Phenomenology of Psychosis in Movement Disorders.
- Single-nucleus RNA-seq identifies Huntington disease astrocyte states.
- Letters.
- Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
- Author Correction: The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington's disease patients.
- Lactobacillus probiotics improved the gut microbiota profile of a Drosophila melanogaster Alzheimer's disease model and alleviated neurodegeneration in the eye.
- Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease.
- The Ripple Effect: A Qualitative Overview of Challenges When Growing Up in Families Affected by Huntington's Disease.
- Imaging mass spectrometry allows for neuroanatomic-specific detection of gangliosides in the healthy and diseased brain.
- Endocannabinoid receptors in the CNS: potential drug targets for the prevention and treatment of neurologic and psychiatric disorders.
- Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease.
- Language disintegration in spontaneous speech in Huntington's disease: a more fine-grained analysis.
- A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo.
- Salivary Redox Biomarkers in Selected Neurodegenerative Diseases.
- Normative data for Emotion Hexagon test and frequency of impairment in behavioral variant frontotemporal dementia, Alzheimer's disease and Huntington's disease.
- LncRNA BDNF-AS promotes autophagy and apoptosis in MPTP-induced Parkinson's disease via ablating microRNA-125b-5p.
- [Gene therapy for central nervous system disorders].
- High-Cholesterol Diet Decreases the Level of Phosphatidylinositol 4,5-Bisphosphate by Enhancing the Expression of Phospholipase C (PLCβ1) in Rat Brain.
- Transcriptome analysis reveals dysregulation of genes involved in oxidative phosphorylation in a murine model of retinopathy of prematurity.
- Hung-up Knee Jerk in Huntington's Disease.
- Gait variability as digital biomarker of disease severity in Huntington's disease.
- Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases.
- GPR6 Structural Insights: Homology Model Construction and Docking Studies.
- Elevated serum α-synuclein levels in huntington's disease patients.
- YKL-40 and neuron-specific enolase in neurodegeneration and neuroinflammation.
- Ellagic acid rescues motor and cognitive deficits in the R6/2 mouse model of Huntington's disease by lowering mutant huntingtin protein.
- Natural and synthetic drugs used for the treatment of the dementia.
- Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington's Disease Patients.
- Basal ganglia role in learning rewarded actions and executing previously learned choices: Healthy and diseased states.
- Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.
- Accuracy of automated amygdala MRI segmentation approaches in Huntington's disease in the IMAGE-HD cohort.
- Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease.
- Reactive oxygen species (ROS) and their impact in neurodegenerative diseases: literature landscape analysis.
- Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease.
- Lack of RAN-mediated toxicity in Huntington's disease knock-in mice.
- Perinatal care in a patient with diagnosed Westphal's disease.
- Stanley Crooke.
- Huntington disease like 2 (HDL-2) with parkinsonism and abnormal DAT-SPECT - A novel observation.
RSS Feed – Literature
HDinHD > RSS Feed – Literature
